08e8f574b38661f723e78f93449c706c197dc11b7ded13b7862e07111168e949726ba2f97cf1009acde00b5d7ba45d8a907f9858

7deb8902b1866af423ec8fe2359c706abc0ee6dc0b04af27cab5aba0fd57fded995585c4880951fe00d6e55d5d33b388d3593f0c

7aed8872c38b60fe239a8696359c706d82f1a9cc6eb2980587082e02c9a18c4d846e14f9e11cea14f5882c85de133c5623147c0d

0ceef303bc80688723ee82e5409c70680023bd6c8b83f278bb67d2d106de895267bcea163c87ff2edd5cf37d2d025b9211303b

7debf673c7841af623eb84e1409c701b64a4bf24cb0a027f50b8a19f534ffbe5f05d3681de32c45216527e5a1dce0b35c21a2f54

0b9f8976c38319f523e7f497449c7068b38f3b8b7b9cba15fd67160446588c0797fe771fadf70fcebd71e8a92a8f58a93409cc73

Now two saponin molecules, made from the bark of branches pruned from older trees in Chile’s forests, are being used for a COVID-19 vaccine developed by drugmaker Novavax Inc (NVAX.O). The chemicals are used to make adjuvant, a substance that boosts the immune system.
Over the next two years, Maryland-based Novavax (NVAX.O) plans to produce billions of doses of the vaccine, mostly for low- and middle-income countries, which would make it one of the largest COVID-19 vaccine suppliers in the world.

74998575b4f06082239c87ed449c7065becadee66b960b823dd29130ed6c5531415c9d085d9b180f94b6e7b50fc9a69ea36a88fa

- dc official App